Parkinson’s disease psychosis

Overview of attention for article published in Research and Reviews in Parkinsonism, March 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 1 news story.

Four months of daily Nuplazid (pimavanserin), an approved oral therapy for psychosis associated with Parkinson’s disease, was…